Literature DB >> 7350667

Schizophrenia: elevated cerebrospinal fluid norepinephrine.

C R Lake, D E Sternberg, D P van Kammen, J C Ballenger, M G Ziegler, R M Post, I J Kopin, W E Bunney.   

Abstract

Concentrations of norepinephrine in cerebrospinal fluid are higher in schizophrenic patients, particularly in those with paranoid features, than in normal volunteer subjects of the same age. This observation supports recent reports of elevated concentrations of norepinephrine in specific brain areas adjacent to the cerebral ventricles of paranoid schizophrenic patients. Overflow of the amine from periventricular regions into the cerebrospinal fluid may reflect abnormally high release or diminished enzymatic destruction of norepinephrine in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350667     DOI: 10.1126/science.7350667

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

1.  Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatment.

Authors:  G Bagdy; A Perenyi; E Frecska; A Seregi; M I Fekete; L Tothfalusi; K Magyar; A Bela; M Arato
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic.

Authors:  L Molander; L Borgström
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

3.  Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load.

Authors:  Katie L Nugent; Joshua Chiappelli; Laura M Rowland; L Elliot Hong
Journal:  Psychoneuroendocrinology       Date:  2015-06-21       Impact factor: 4.905

4.  Hypersensitivity to d-amphetamine several years after early social deprivation in rhesus monkeys.

Authors:  G W Kraemer; M H Ebert; C R Lake; W T McKinney
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology.

Authors:  F Müller-Spahn; M Ackenheil; M Albus; C Botschev; D Naber; D Welter
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Electrophysiologic interactions of antipsychotic drugs with central noradrenergic pathways.

Authors:  J Marwaha; B J Hoffer; H M Geller; R Freedman
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice.

Authors:  Michael A Siuta; Sabrina D Robertson; Heidi Kocalis; Christine Saunders; Paul J Gresch; Vivek Khatri; Chiyo Shiota; J Philip Kennedy; Craig W Lindsley; Lynette C Daws; Daniel B Polley; Jeremy Veenstra-Vanderweele; Gregg D Stanwood; Mark A Magnuson; Kevin D Niswender; Aurelio Galli
Journal:  PLoS Biol       Date:  2010-06-08       Impact factor: 8.029

8.  Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia.

Authors:  Igor Elman; David Rott; Alan I Green; Daniel D Langleben; Scott E Lukas; David S Goldstein; Alan Breier
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

9.  Sedative effects and prolactin response to single oral doses of melperone.

Authors:  L Molander; L Borgström
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?

Authors:  R L Singhal; R B Rastogi; Y D Lapierre
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.